Literature DB >> 15758391

Osteosarcoma: clinical practice and the expanding role of biology.

R Gorlick1.   

Abstract

Entities:  

Year:  2002        PMID： 15758391

Source DB:  PubMed          Journal:  J Musculoskelet Neuronal Interact        ISSN： 1108-7161            Impact factor:   2.041


× No keyword cloud information.
  12 in total

1.  High-throughput genotyping in osteosarcoma identifies multiple mutations in phosphoinositide-3-kinase and other oncogenes.

Authors:  Edwin Choy; Francis Hornicek; Laura MacConaill; David Harmon; Zeeshan Tariq; Levi Garraway; Zhenfeng Duan
Journal:  Cancer       Date:  2011-10-17       Impact factor: 6.860

2.  Individualized chemotherapy for osteosarcoma and identification of gene mutations in osteosarcoma.

Authors:  Xin Xiao; Wei Wang; Haoqiang Zhang; Peng Gao; Bo Fan; Chen Huang; Jun Fu; Guojing Chen; Lei Shi; Haodong Zhu; Xiangdong Li; Jing Li; Hongbin Fan; Zhigang Wu; Zheng Guo; Yongcheng Hu; Sujia Wu; Xiuchun Yu; Cheng Xu; Zhen Wang
Journal:  Tumour Biol       Date:  2014-11-28

3.  COL1A1 polymorphism is associated with risks of osteosarcoma susceptibility and death.

Authors:  Maolin He; Zhe Wang; Jinmin Zhao; Yingbin Chen; Yang Wu
Journal:  Tumour Biol       Date:  2013-09-27

4.  Expression analysis of genes associated with human osteosarcoma tumors shows correlation of RUNX2 overexpression with poor response to chemotherapy.

Authors:  Bekim Sadikovic; Paul Thorner; Susan Chilton-Macneill; Jeff W Martin; Nilva K Cervigne; Jeremy Squire; Maria Zielenska
Journal:  BMC Cancer       Date:  2010-05-13       Impact factor: 4.430

5.  Effect of c-erbB2 overexpression on prognosis in osteosarcoma: evidence from eight studies.

Authors:  Yu Liu; Yun-Hong Ma; Zhen-Zhong Sun; Yong-Jun Rui; Qu-Dong Yin; Sheng Song; Xu-Ming Wei; Jun Liu; Xue-Guang Liu; Ke-Jia Hu
Journal:  Tumour Biol       Date:  2014-06-05

6.  The prognostic role of CD133 expression in patients with osteosarcoma.

Authors:  Nuo Xu; Yijun Kang; Wanchun Wang; Jian Zhou
Journal:  Clin Exp Med       Date:  2020-02-12       Impact factor: 3.984

7.  Quantitative assessment of the association of COX-2 (Cyclooxygenase-2) immunoexpression with prognosis in human osteosarcoma: a meta-analysis.

Authors:  Zhe Wang; Maolin He; Zengming Xiao; Hao Wu; Yang Wu
Journal:  PLoS One       Date:  2013-12-16       Impact factor: 3.240

8.  Prognostic role of CD44 expression in osteosarcoma: evidence from six studies.

Authors:  Yu Liu; Yongwei Wu; Sanjun Gu; Zhenzhong Sun; Yongjun Rui; Jianbing Wang; Yao Lu; Haifeng Li; Kelin Xu; Peng Sheng
Journal:  Diagn Pathol       Date:  2014-08-11       Impact factor: 2.644

9.  ARHGEF3 Associated with Invasion, Metastasis, and Proliferation in Human Osteosarcoma.

Authors:  Jie Gong; Wei Tang; Bin Lv; Shushu Zhang; Tingjuan Fan; Guangyu Gao; Dong Chen; Yulong Liu
Journal:  Biomed Res Int       Date:  2021-07-24       Impact factor: 3.411

10.  High CD49f expression is associated with osteosarcoma tumor progression: a study using patient-derived primary cell cultures.

Authors:  Patrice Penfornis; David Z Cai; Michael R Harris; Ryan Walker; David Licini; Joseph D A Fernandes; Griffin Orr; Tejaswi Koganti; Chindo Hicks; Spandana Induru; Mark S Meyer; Rama Khokha; Jennifer Barr; Radhika R Pochampally
Journal:  Cancer Med       Date:  2014-05-07       Impact factor: 4.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.